We are honored to partner with CureAge in advancing innovative gene-based approaches that have the potential to change the trajectory of neurofibromatosis.

At CureNFwithJack, we believe patients cannot wait. We are committed to investing in bold, translational science that can accelerate meaningful progress from the laboratory to patients—with urgency, with hope, and with an unwavering focus on delivering better treatments and, ultimately, a cure." — Elizabeth O'Brien, Co-Founder and CEO of CureNFwithJack Read the full press release here: https://www.cureagetx.com/press-releases/curenfwithjack-joins-cureage-therapeutics #EndNF #NFStrong #staywithjack